AI English summary of an SEC filing — figures as filed

The company said revenue for the first quarter of fiscal 2026, which ended July 25, was $8.578 billion, up 8.4% as reported and 4.8% organic. Adjusted revenue was $8.539 billion. Quarter: Q1.

8-KResults of Operations and Financial ConditionFiled Aug 19, 2025Period of report Aug 18, 2025Summary published (UTC) Oct 9, 2026

Key points

AI summary

The company said revenue for the first quarter of fiscal 2026, which ended July 25, was $8.578 billion, up 8.4% as reported and 4.8% organic. Adjusted revenue was $8.539 billion. Quarter: Q1.
The company said GAAP net income for Q1 was flat at $1.040 billion, and GAAP diluted EPS was $0.81, up 1%. Non-GAAP diluted EPS was $1.26, up 2%.
The company said it raised its full-year non-GAAP diluted EPS guidance from $5.50 to $5.60 to $5.60 to $5.66, and that the tariff impact fell from approximately $200 million to $350 million to approximately $185 million.
The company said operating cash flow for Q1 was $1,088 million, and free cash flow after capital expenditures of $504 million was $584 million. Free cash flow for the same quarter last year was $466 million.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Medtronic revenue of $8.578 billion for Q1, organic growth of 4.8%

The company said revenue for the first quarter of fiscal 2026, which ended July 25, was $8.578 billion, up 8.4% as reported and 4.8% organic. Adjusted revenue was $8.539 billion. Quarter: Q1.

Source · Based on the filing body and exhibits

GAAP net income of $1.040 billion, diluted EPS of $0.81

The company said GAAP net income for Q1 was flat at $1.040 billion, and GAAP diluted EPS was $0.81, up 1%. Non-GAAP diluted EPS was $1.26, up 2%.

Source · Based on the filing body and exhibits

Full-year EPS guidance of $5.60 to $5.66, tariff impact of approximately $185 million

The company said it raised its full-year non-GAAP diluted EPS guidance from $5.50 to $5.60 to $5.60 to $5.66, and that the tariff impact fell from approximately $200 million to $350 million to approximately $185 million.

Source · Based on the filing body and exhibits

Medtronic operating cash flow of $1,088 million for Q1, free cash flow of $584 million

The company said operating cash flow for Q1 was $1,088 million, and free cash flow after capital expenditures of $504 million was $584 million. Free cash flow for the same quarter last year was $466 million.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.